* CEZANNE *
2000 - Méditerranée
Nîmes
www.cezanne.fr Development, Devices
Key words: Immunochemistry analysis, Kryptor analyser, Fluorescence detection, Trace technology, Automatic instruments, Reagents
Mission: to develop innovating diagnostics products, notably the the Kryptor system, a software and fluorescence reading system (supplied as an OEM component for Pharma research groups)
Clients: Pharma industry, R&D labs
contact@cezanne.fr
Age: 9 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Personal venture |
Managing Dir.-CEO: Bois (Emmanuel) [co-founder, born 1960]
Sc.Dir.-CSO: Bois (Emmanuel)
Fin.Dir.-CFO:
BusDev:
Financers (Hist.): | Turnover (M€) : 17.1 (2008), 12.8 (2006)
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Multiple
Position : Trade
Company confirm : neutral |
History | DATE | MILESTONE | TYPE | TIME | | 2009 .06 | Partnering research agreement with Brahms (Germany) and Lumiphore (USA), with incorporation of Lumiphore’s complexes into diagnostic tests | R&D | [9 years] |
| 2003 .09 | Partnering sales agreement with Brahms (Germany) as exclusive distributor | MKTG | [3 years] |
| 2003 .09 | Company move to Nîmes, after floods devastated the initial premises in September 2002 | ORGL | [3 years] |
| 2000 .06 | Company founded by Emmanuel Bois and others, in Bagnols-sur-Cèze, to continue the divested diagnostics activities by CisBio International, after their acquisition by Schering AG | ORGF | [0 year] | Actualisation / Updating: 11-Sept-2009 |
|
